Scarica l'app Stockscreener
57.94
2.90%
-1.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
ANI Pharmaceuticals (ANIP) Expected to Post Earnings on Friday - Defense World
ANI Pharmaceuticals to Present at Raymond James’ - GlobeNewswire
ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in March - The Manila Times
Inside Access: ANI Pharmaceuticals Sets Stage for Dual Healthcare Conference ShowcaseKey Dates for Investors - StockTitan
ANI Pharmaceuticals (ANIP) Shares Cross Above 200 DMA - Nasdaq
Ani Pharmaceuticals Sr. VP sells $23,816 in stock By Investing.com - Investing.com Canada
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year - GlobeNewswire
ANI Pharmaceuticals, Inc. to Release Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 - Nasdaq
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET - The Manila Times
ANI Pharmaceuticals Earnings: Rare Disease Portfolio Performance and 2025 Growth Strategy Revealed - StockTitan
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now? - Yahoo Finance
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance
Legato Capital Management LLC Takes $334,000 Position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Rating of “Buy” by Analysts - Defense World
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Rating of "Buy" by Analysts - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group - Financial Content
abrdn plc Makes New $13.16 Million Investment in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals: More Than Just A Generics Company (NASDAQ:ANIP) - Seeking Alpha
ANI Pharmaceuticals (NASDAQ:ANIP) Rating Increased to Hold at StockNews.com - MarketBeat
Pacer Advisors Inc. Sells 566,516 Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals Shares Strategic Insights at Conference - TipRanks
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Holdings Decreased by Pacer Advisors Inc. - Defense World
ANI Pharmaceuticals (NASDAQ:ANIP) Upgraded to “Hold” at StockNews.com - Defense World
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Sees Significant Decline in Short Interest - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell" Rating by StockNews.com - MarketBeat
9,843 Shares in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Bought by SG Americas Securities LLC - Defense World
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is ANI Pharmaceuticals (ANIP) Stock Undervalued Right Now? - Nasdaq
Investing in ANI Pharmaceuticals (NASDAQ:ANIP) three years ago would have delivered you a 53% gain - Yahoo Finance
StockNews.com Downgrades ANI Pharmaceuticals (NASDAQ:ANIP) to Sell - Defense World
ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference - GlobeNewswire
ANI Pharma CEO Reveals Future Strategy: Key Insights Coming at Major Biotech Event - StockTitan
ANI Pharmaceuticals (ANIP) Stock Price, News & Analysis - MarketBeat
Clostridium Difficile Infection Treatment Market Size Worth US$ 2.28 Billion by 2034 at a CAGR Of 6.3% | Fact.MR Report - GlobeNewswire
Millennium Management LLC's Strategic Acquisition in ANI Pharmac - GuruFocus.com
ANI Maintains Course With Rare Disease Push In 2025 - News & Insights
Wedge Capital Management L L P NC Trims Stake in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
Brokerages Set ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Price Target at $77.71 - MarketBeat
Gastroparesis Drugs Market to Grow by USD 1.34 Billion (2025-2029), Driven by Rising Global Diabetes Burden, AI's Role in Market TransformationTechnavio - Yahoo Finance
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal - MSN
Short Interest in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Declines By 8.5% - MarketBeat
Assenagon Asset Management S.A. Raises Stock Holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) delivers shareholders respectable 12% CAGR over 3 years, surging 6.2% in the last week alone - Simply Wall St
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Southwest Airlines, Silexion Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Is ANI Pharmaceuticals (ANIP) a Great Value Stock Right Now? - Yahoo Finance
ANI Pharma To Present At 43rd Annual J.P. Morgan Healthcare Conference; Webcast At 5:15 PM ET - Nasdaq
Insider Selling: ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) VP Sells 400 Shares of Stock - MarketBeat
Ani Pharmaceuticals senior VP sells $21,568 in stock By Investing.com - Investing.com Nigeria
Ani Pharmaceuticals senior VP sells $21,568 in stock - Investing.com
ANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 52-Week LowHere's What Happened - MarketBeat
Alcami Announces CEO Transition - Quantisnow
ANI Pharmaceuticals Projects Strong Growth for 2025 - TipRanks
ANI Pharmaceuticals, Inc. Affirms Earnings Guidance for the Year 2024 and Provides Earnings Guidance for the Full Year 2025 - Marketscreener.com
ANI Pharmaceuticals Projects Strong 25% Growth for 2025, Exceeds 2024 Guidance Targets - StockTitan
3.23%
3.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):